NCT04534075
Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial No drug interventions prevention 3 recruiting NCT02228330
Prospective Clinical Trial - Obturator Reflex Predictors and Blockage No drug interventions treatment Not Available unknown_status NCT04977453
GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors treatment 1 / 2 recruiting NCT04812145
Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma No drug interventions Not Available Not Available unknown_status NCT02139371
Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography No drug interventions diagnostic 0 completed NCT01836978
Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy No drug interventions supportive_care Not Available completed NCT00462488
Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ treatment 2 completed NCT05335707
Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy No drug interventions Not Available Not Available withdrawn NCT03636256
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma treatment 1 / 2 completed NCT03335059
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. treatment 3 terminated NCT03433924
An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients. No drug interventions Not Available Not Available completed NCT02437539
Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography No drug interventions diagnostic 1 completed NCT00384891
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer No drug interventions treatment 3 terminated NCT02720367
Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer treatment 1 completed NCT04525781
Clinicoepidimiological Study and Clinical Outcome in Patients With Urinary Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT00872495
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer No drug interventions Not Available Not Available recruiting NCT05787938
Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection No drug interventions Not Available Not Available not_yet_recruiting NCT03529890
Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder treatment 2 unknown_status NCT03998579
Physical Rehabilitation Among Patients Undergoing Radical Cystectomy Due to Urinary Bladder Cancer No drug interventions treatment Not Available completed NCT06156787
Patterns of Urinary Bladder Cancer in Darfur, Suda No drug interventions Not Available Not Available completed NCT03844256
A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study treatment 1 / 2 recruiting NCT05621837
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy No drug interventions Not Available Not Available unknown_status NCT05072600
Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer treatment 2 recruiting NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential Needs No drug interventions health_services_research Not Available not_yet_recruiting NCT05644041
Intravesical Gemcitabine in Patients With NMIBC treatment 2 recruiting NCT05822934
Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer treatment 3 active_not_recruiting NCT06115434
Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical Cystectomy No drug interventions Not Available Not Available recruiting NCT03132922
MAGE-A4ᶜ¹º³²T for Multi-Tumor No drug interventions treatment 1 active_not_recruiting NCT04718948
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine No drug interventions Not Available Not Available unknown_status NCT04635566
Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute treatment Not Available completed NCT02897765
A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer treatment 1 completed NCT01374789
PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer treatment 2 terminated NCT06307704
Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients No drug interventions supportive_care Not Available recruiting NCT05946369
Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT02722538
Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer treatment 1 completed NCT04861584
Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects treatment 2 recruiting NCT01785537
The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study No drug interventions Not Available Not Available unknown_status NCT03133286
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) No drug interventions Not Available Not Available completed NCT03063255
Comparison of Obturator Nerve Blockade and Neuromuscular Blockade basic_science 4 completed NCT04127318
Low-moderate Intensity Pedaling During Immunotherapy Administration No drug interventions treatment Not Available withdrawn NCT03301493
Genomic Testing and Resulting Medical Decisions No drug interventions Not Available Not Available recruiting NCT05822518
Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy prevention Not Available completed NCT05324033
Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer No drug interventions Not Available Not Available completed NCT05278598
3 Ultrasound Guided Plane Blocks for Perioperative Analgesia in Patients Undergoing Radical Cystectomy No drug interventions supportive_care Not Available completed NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT05262166
Opioid Free Anesthesia in Prolonged Surgery supportive_care Not Available unknown_status NCT01264744
Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test) No drug interventions Not Available Not Available completed NCT01868087
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study No drug interventions treatment 0 completed NCT00014287
Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer treatment 1 withdrawn NCT02307487
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients treatment 2 completed NCT01273987
Neobladder Posterior Wall Suspended With Round Ligament of Uterus No drug interventions treatment Not Available completed NCT00042887
Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer treatment 3 terminated NCT03597087
The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study No drug interventions treatment Not Available unknown_status NCT00729287
Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer No drug interventions treatment 3 completed NCT00582387
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT01076387
Randomized Trial Comparing Robotic and Open Radical Cystectomy No drug interventions treatment 3 completed NCT04339933
Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT06551233
Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) No drug interventions treatment 1 recruiting NCT03718754
En-bloc vs Conventional Resection of Primary Bladder Tumor No drug interventions treatment 3 completed NCT00004154
Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer treatment 3 completed NCT04687254
Gender-related Characteristics of Bladder Cancer Treatment No drug interventions Not Available Not Available unknown_status NCT03801954
Implementation of Nutrition Education Videos for Patients Undergoing Radical Cystectomy No drug interventions Not Available Not Available completed NCT00880854
Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer treatment 1 withdrawn NCT03532451
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer treatment 1 completed NCT05180851
Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study No drug interventions treatment 0 unknown_status NCT00006351
SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract treatment 2 completed NCT05975151
Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer treatment 2 recruiting NCT02050451
Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy No drug interventions prevention Not Available completed NCT01956253
Single Subject Neratinib in Bladder Cancer (NRR) Not Available Not Available no_longer_available NCT05488353
A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma treatment 4 not_yet_recruiting NCT04018053
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy diagnostic 0 active_not_recruiting NCT00722553
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder treatment 2 completed NCT00186277
Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer treatment 2 completed NCT03739177
Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients No drug interventions Not Available Not Available unknown_status NCT06170177
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy No drug interventions Not Available Not Available recruiting NCT06205277
Predictors of Residual Tumor at Second Transurethral Resection for pT1 Non-muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT05056077
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) No drug interventions supportive_care Not Available recruiting NCT04235777
Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies treatment 1 recruiting NCT01844947
Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract treatment 1 completed NCT02371447
VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer treatment 1 / 2 completed NCT04799847
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine treatment 1 / 2 recruiting NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO No drug interventions treatment 3 recruiting NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors treatment 1 recruiting NCT01780545
Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer treatment 2 completed NCT00553345
Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer prevention 3 unknown_status NCT03347045
Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care No drug interventions treatment Not Available unknown_status NCT02660645
Blue Light Cystoscopy With Cysview® Registry Not Available Not Available recruiting NCT05655598
TAS-116 Plus Palbociclib in Breast and Rb-null Cancer treatment 1 recruiting NCT04228198
Protocol of the Italian Radical Cystectomy Registry No drug interventions Not Available Not Available unknown_status NCT05578898
CLEAR Care Companion Application No drug interventions supportive_care Not Available recruiting NCT03652298
Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners No drug interventions prevention 2 terminated NCT03986398
Nosocomial Infections During Total Prostatic Cystectomies (TPC) With Replacement Enterocystoplasty: Prophylactic Role of Urell®, Cranberry Fruit Juice Extract (Vaccicium Macrocarpon) No drug interventions prevention Not Available terminated NCT02153905
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive treatment 1 / 2 terminated NCT06337305
Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer No drug interventions Not Available Not Available completed NCT01284205
First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC No drug interventions treatment 3 withdrawn NCT03058705
Near Infrared Fluorescence Imaging for Bladder Cancer Detection device_feasibility Not Available completed NCT00006105
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer treatment 2 completed NCT02993497
Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia No drug interventions supportive_care Not Available completed NCT01627197
Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer No drug interventions treatment 3 unknown_status NCT05833997
Safety Analysis and Oncological Outcomes in HoLERT vs TURBT No drug interventions treatment Not Available recruiting NCT03982797
Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis No drug interventions treatment 2 unknown_status NCT06408597
Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy No drug interventions supportive_care Not Available recruiting NCT02886897
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT01826097
Improving Sensitivity of Urine Cytology for Bladder Cancer No drug interventions screening Not Available withdrawn NCT05564897
Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer treatment 2 recruiting NCT03327883
Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT02281383
Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer No drug interventions treatment 2 completed NCT04110483
Thulium Fiber Laser En-bloc Resection vs Conventional Transurethral Resection of Non-muscle-invasive Bladder Cancer No drug interventions treatment Not Available completed NCT05899361
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest No drug interventions diagnostic Not Available recruiting NCT04256161
Measurements of Sexual Steroids' Concentrations in Prostatic Tissue No drug interventions Not Available Not Available completed NCT04317261
Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria No drug interventions diagnostic Not Available completed NCT06138561
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments No drug interventions Not Available Not Available recruiting NCT02781428
To Detect the Sensitivity of the UroMark Assay No drug interventions Not Available Not Available completed NCT05148728
Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors No drug interventions treatment Not Available unknown_status NCT04138628
Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy diagnostic 2 recruiting NCT00089128
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer treatment 2 terminated NCT06390111
A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose. treatment 4 recruiting NCT00006111
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract treatment 2 completed NCT04055311
Recovery Support for Bladder Cancer Patients and Caregivers No drug interventions supportive_care Not Available recruiting NCT02993211
Transurethral En Bloc Versus Standard Resection of Bladder Tumour No drug interventions treatment Not Available completed NCT04402411
Quadratus Lumborum Block vs Transversus Abdominis Plane Block in Bladder Cancer Surgeries No drug interventions other Not Available unknown_status NCT00310011
Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium treatment 2 completed NCT03909893
A Study of Adaptive Radiation Therapy for Pelvic Genitourinary Cancer No drug interventions treatment Not Available withdrawn NCT01710293
Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis No drug interventions health_services_research Not Available withdrawn NCT00645593
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer treatment 2 completed NCT05312671
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer treatment 2 recruiting NCT00412971
A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer diagnostic 3 completed NCT04610671
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC treatment 1 active_not_recruiting NCT00666978
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking treatment 4 completed NCT00776178
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health No drug interventions Not Available Not Available completed NCT06341478
Investigator Grant (IG) 2022 27746 No drug interventions other Not Available recruiting NCT04923178
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies No drug interventions Not Available Not Available recruiting NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 2 recruiting NCT04806178
Immunological Response of Bladder Cancer Patients Under BCG No drug interventions treatment 3 suspended NCT03254888
Autophagy Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT00397488
Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium treatment 2 completed NCT05260788
Mapping 3D Bladder No drug interventions Not Available Not Available withdrawn NCT04321707
Complete Local Response to Neoadjuvant Chemotherapy in Patients With Muscle Invasive Bladder Cancer Evaluated by 15O-H2O PET/MR No drug interventions diagnostic Not Available unknown_status NCT03973307
UroX Biomarker Bladder Cancer Study No drug interventions Not Available Not Available recruiting NCT05235607
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors No drug interventions treatment 1 unknown_status NCT04492007
Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) No drug interventions supportive_care Not Available completed NCT04254107
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer treatment 1 terminated NCT02302807
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] treatment 3 completed NCT05643807
Bladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is Better? No drug interventions diagnostic Not Available recruiting NCT01329107
Multimodal Rehabilitation Program to Bladder Cancer Patients No drug interventions prevention Not Available completed NCT01732107
Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression treatment 2 terminated NCT02662309
Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder treatment 2 unknown_status NCT04917809
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer treatment 2 recruiting NCT02538809
Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals No drug interventions Not Available Not Available recruiting NCT02753309
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer treatment 0 completed NCT01916109
Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer treatment 2 terminated NCT04534309
Behavioral Weight Loss Program for Cancer Survivors in Maryland No drug interventions prevention Not Available completed NCT00661609
A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer No drug interventions treatment 2 completed NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients No drug interventions diagnostic Not Available recruiting NCT06364956
Phase Ib/II Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma treatment 1 / 2 recruiting NCT03629756
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies treatment 1 completed NCT00981656
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer treatment 2 completed NCT05193656
Bladder Cancer Detection Using Convolutional Neural Networks No drug interventions Not Available Not Available recruiting NCT00014456
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT03924856
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866) treatment 3 active_not_recruiting NCT04625556
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome No drug interventions Not Available Not Available recruiting NCT01444456
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia No drug interventions Not Available Not Available completed NCT00971256
Urine Cytology and Utility in Bladder Recurrence No drug interventions Not Available Not Available completed NCT04580485
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors treatment 1 completed NCT01162785
1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer treatment 1 completed NCT04610385
Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy No drug interventions Not Available Not Available unknown_status NCT04157985
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors treatment 3 recruiting NCT04106115
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr treatment 1 / 2 recruiting NCT06034015
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers No drug interventions treatment 1 not_yet_recruiting NCT00847015
Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer treatment 2 completed NCT05195515
The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life No drug interventions Not Available Not Available enrolling_by_invitation NCT01738815
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer basic_science 0 completed NCT01840137
Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer No drug interventions treatment Not Available completed NCT00052637
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer diagnostic 3 completed NCT02704832
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) No drug interventions other 3 unknown_status NCT06026332
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States Not Available Not Available recruiting NCT00627432
Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer treatment 2 suspended NCT03517332
Circulating Tumor DNA Exposure in Peripheral Blood No drug interventions Not Available Not Available unknown_status NCT04184232
Treatment of Recurrent Bladder Cancer With Dendritic Cells No drug interventions treatment 2 completed NCT03434132
Open Versus Robot Assisted Radical Cystectomy With Totally Intracorporeal Urinary Diversion. No drug interventions treatment Not Available completed NCT02108652
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2) treatment 2 completed NCT00066352
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter treatment 2 completed NCT03836352
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors treatment 2 active_not_recruiting NCT05077852
Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder No drug interventions Not Available Not Available unknown_status NCT05544552
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations No drug interventions treatment 1 / 2 recruiting NCT02852252
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry Not Available Not Available completed NCT01339000
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy treatment 2 terminated NCT03266900
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival No drug interventions treatment 0 terminated NCT01489800
The Impact of Early Feeding After Radical Cystectomy for Bladder Cancer No drug interventions supportive_care Not Available completed NCT02993900
Image-Guided Gynecologic Brachytherapy No drug interventions treatment Not Available recruiting NCT04742959
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT00963859
Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder No drug interventions treatment 2 completed NCT04947059
Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline) prevention 3 recruiting NCT04155359
Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients No drug interventions Not Available Not Available active_not_recruiting NCT00003759
AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer treatment 2 completed NCT04060459
Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer treatment 2 unknown_status NCT05710159
The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients No drug interventions Not Available Not Available recruiting NCT06245759
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients No drug interventions Not Available Not Available recruiting NCT00342875
The New England Bladder Cancer Study No drug interventions Not Available Not Available completed NCT01031875
Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment treatment 2 completed NCT00237575
Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer treatment 3 terminated NCT00136175
Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder treatment 2 completed NCT02897375
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors treatment 1 completed NCT00003175
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer treatment 2 completed NCT05978570
Physical Therapy in Pre-cystectomy Patients No drug interventions supportive_care Not Available recruiting NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06493370
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer treatment 2 not_yet_recruiting NCT03193970
Measuring Surgical Recovery After Radical Cystectomy No drug interventions Not Available Not Available recruiting NCT06337942
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study No drug interventions treatment Not Available recruiting NCT02164942
LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer No drug interventions Not Available Not Available terminated NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S No drug interventions treatment 1 completed NCT00023842
BCG With or Without Mitomycin in Treating Patients With Bladder Cancer treatment 2 completed NCT04690699
LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy of Lerapolturev (PVSRIPO) and Lerapolturev in Combination With Anti-PD-1/L1 Checkpoint Inhibitors in Patients With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT00313599
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT05204199
Role of Microbiome in BCG Responsiveness Prediction No drug interventions Not Available Not Available recruiting NCT06331299
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer treatment 3 recruiting NCT03147599
Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders treatment 4 completed NCT01447199
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) No drug interventions Not Available Not Available unknown_status NCT00082706
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant treatment 2 active_not_recruiting NCT00578006
Internet-based System for Cancer Patients to Self-report Toxicity No drug interventions Not Available Not Available completed NCT05649306
Gender Related Coping and Survivorship for Genitourinary Cancers No drug interventions Not Available Not Available recruiting NCT04129606
Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy No drug interventions diagnostic Not Available unknown_status NCT03296306
Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma treatment 3 unknown_status NCT01697306
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer Not Available 2 completed NCT03993249
Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy treatment 2 unknown_status NCT02252549
An International Randomized Study to Compare SPIES Versus WLI No drug interventions diagnostic Not Available completed NCT01126749
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer treatment 1 / 2 terminated NCT02027649
Detection of K14 in Bladder Cancer With a Non Invasive Technique No drug interventions Not Available Not Available terminated NCT00583349
Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer treatment 1 / 2 unknown_status NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04683536
Bakircay University Cigli Training and Research Hospital No drug interventions Not Available Not Available completed NCT02203136
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging No drug interventions Not Available Not Available completed NCT06269536
Stress-reducing Intervention in Urothelial Carcinoma No drug interventions supportive_care Not Available recruiting NCT00635336
Novel Peptide Vaccination for Patients With Advanced Bladder Cancer No drug interventions treatment 1 completed NCT00913536
Cone Beam Computed Tomography (CT) Bladder No drug interventions treatment Not Available completed NCT01489813
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment treatment 2 active_not_recruiting NCT01869413
Tranexamic Acid During Cystectomy Trial (TACT) prevention 2 / 3 completed NCT05057013
HMBD-001 in Advanced HER3 Positive Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT00006118
Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer treatment 2 unknown_status NCT06440018
INSPIRE: A Multi-Cancer Early Detection Study No drug interventions Not Available Not Available not_yet_recruiting NCT04358718
Influence of Opioids on Circulating Tumor Cells in Radical Cystectomy No drug interventions prevention Not Available completed NCT06355518
Pre-operative Immuno-Nutrition in Radical Cystectomy No drug interventions treatment Not Available not_yet_recruiting NCT04724018
Sacituzumab Govitecan Plus EV in Metastatic UC treatment 1 active_not_recruiting NCT03023319
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors treatment 1 completed NCT03007719
Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1 No drug interventions diagnostic 2 terminated NCT03747419
Avelumab and Radiation in Muscle-Invasive Bladder Cancer treatment 2 recruiting NCT01675219
Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) treatment 3 active_not_recruiting NCT01060319
A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies No drug interventions Not Available Not Available withdrawn NCT04567719
Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer No drug interventions Not Available Not Available active_not_recruiting NCT06389019
Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder Cancer No drug interventions Not Available Not Available recruiting NCT03980041
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) treatment 2 completed NCT03718741
Prospective Study of Adjuvant Radiotherapy in High Risk Bladder Cancer. No drug interventions treatment Not Available terminated NCT06193941
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits No drug interventions Not Available Not Available completed NCT04190641
Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder No drug interventions diagnostic Not Available completed NCT02091141
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors treatment 2 completed NCT00002917
Paclitaxel in Treating Patients With Early-Stage Bladder Cancer treatment 1 / 2 completed NCT02328417
Enhanced Recovery After Radical Cystectomy Study No drug interventions Not Available Not Available completed NCT04602117
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer treatment 1 withdrawn NCT00880334
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC treatment 2 completed NCT05392634
Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery prevention 3 unknown_status NCT00014534
Combination Chemotherapy in Treating Patients With Bladder Cancer treatment 3 completed NCT03427034
Assessment of BladderLight SurvEILlance No drug interventions diagnostic 2 / 3 unknown_status NCT05024734
Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids treatment 2 recruiting NCT04442724
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy No drug interventions treatment Not Available recruiting NCT03978624
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer treatment 2 active_not_recruiting NCT05697224
Aschistosoma Haematobiumspecific microRNAas a Tumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt No drug interventions diagnostic Not Available not_yet_recruiting NCT01331824
Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma treatment 2 terminated NCT06091124
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma treatment 2 recruiting NCT00003824
S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer treatment 3 terminated NCT02700724
Observation Versus Immediate Surgery of Low Risk Bladder Cancer No drug interventions treatment Not Available terminated NCT04700124
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304) treatment 3 active_not_recruiting NCT00957424
Acceptability of Less Harmful Alternatives to Cigarettes Not Available Not Available completed NCT00047216
Tipifarnib in Treating Patients With Recurrent Bladder Cancer treatment 2 completed NCT05167916
Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy? No drug interventions diagnostic Not Available unknown_status NCT04256616
Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT03628716
CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer treatment 2 completed NCT03108196
Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder No drug interventions treatment Not Available recruiting NCT00393796
Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma treatment 2 terminated NCT02861196
Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer No drug interventions treatment Not Available completed NCT00491296
Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia No drug interventions Not Available Not Available unknown_status NCT05259696
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) treatment 1 / 2 active_not_recruiting NCT03498196
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer treatment 1 / 2 terminated NCT03759496
Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer treatment 2 unknown_status NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy No drug interventions treatment 1 / 2 completed NCT06324058
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC No drug interventions treatment Not Available not_yet_recruiting NCT00126958
Cost-Effectiveness in Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients No drug interventions supportive_care Not Available completed NCT01007058
Markers of Response to Intravesical Bladder Cancer Therapy No drug interventions Not Available Not Available completed NCT00005958
Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer treatment 2 unknown_status NCT00005858
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer No drug interventions treatment 1 completed NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours No drug interventions treatment 1 recruiting NCT02373735
Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes No drug interventions supportive_care Not Available completed NCT00019435
LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT06111235
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT treatment 3 recruiting NCT00055835
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium treatment 2 completed NCT03694535
Intravesical Thermochemotherapy With Mitomycin-c prevention Not Available completed NCT03345563
Project HERO: Health Empowerment & Recovery Outcomes No drug interventions supportive_care Not Available active_not_recruiting NCT04223063
Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study No drug interventions supportive_care Not Available unknown_status NCT01259063
RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder treatment 1 / 2 completed NCT04897763
Assessment of safEty, Tolerability, Radiation Dosimetry, and Imaging Properties of 89Zr-labeled giRenTuximab (89Zr-Girentuximab) in patIents With Non-musclE-iNvasive Bladder CancEr (NMIBC) No drug interventions diagnostic 0 completed NCT01015963
Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871 No drug interventions Not Available Not Available completed NCT04089163
A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8) treatment 1 withdrawn NCT05503563
A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder No drug interventions Not Available Not Available recruiting NCT02238886
Radical Cystectomy, Nutrition and Convalescence No drug interventions supportive_care Not Available completed NCT03147586
Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy treatment 4 unknown_status NCT05204186
Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence No drug interventions Not Available Not Available recruiting NCT02449239
Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG treatment 3 completed NCT05111639
Decision Making for Urinary Diversion in Patients With Bladder Cancer No drug interventions Not Available Not Available recruiting NCT01118039
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer treatment 2 unknown_status NCT02665039
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function treatment 2 completed NCT00808639
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma treatment 2 completed NCT04256122
Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy No drug interventions Not Available Not Available unknown_status NCT02178722
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers treatment 1 / 2 completed NCT06488222
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer treatment 2 not_yet_recruiting NCT05600322
Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer diagnostic 3 completed NCT00004122
BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer treatment 2 completed NCT03063125
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer No drug interventions Not Available Not Available completed NCT05123625
Relationship Between Lymph Node Dissection and Prognosis in High-risk NMIBC No drug interventions treatment Not Available recruiting NCT02951325
Bladder Cancer Adjuvant Radiotherapy Trial No drug interventions treatment Not Available unknown_status NCT00465725
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors treatment 1 completed NCT03065725
Early Versus Late FDG-PET/CT in Bladder Cancer No drug interventions Not Available Not Available completed NCT03022825
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer treatment 2 / 3 active_not_recruiting NCT01395225
Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer No drug interventions Not Available Not Available completed NCT03171025
Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer treatment 2 active_not_recruiting NCT05856825
Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World Study No drug interventions Not Available Not Available not_yet_recruiting NCT00792025
Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer treatment 2 completed NCT00003930
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer treatment 1 / 2 completed NCT04958330
Lateral Prostate Capsule Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male No drug interventions Not Available Not Available unknown_status NCT01166230
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB No drug interventions Not Available Not Available completed NCT00045630
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium treatment 2 completed NCT00891748
Safety Study on AdCD40L Gene Therapy for Bladder Cancer No drug interventions treatment 1 / 2 completed NCT04089748
Basal Tumours in Bladder Cancer, Response to chemoTherapy No drug interventions Not Available Not Available unknown_status NCT06009848
Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer treatment 2 recruiting NCT01810757
Study of Weekly Radiotherapy for Bladder Cancer No drug interventions treatment Not Available active_not_recruiting NCT05679557
Comprehensive Geriatric Assessment for Perioperative Optimization in Cystectomy No drug interventions treatment Not Available recruiting NCT05829057
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 No drug interventions treatment 1 recruiting NCT01426126
Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum No drug interventions treatment 2 completed NCT00006026
Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract treatment 2 completed NCT00612326
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging No drug interventions Not Available Not Available completed NCT00635726
Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer treatment 2 terminated NCT00578526
SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial treatment 2 completed NCT02886026
Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors No drug interventions treatment Not Available unknown_status NCT01935466
Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE" Not Available Not Available completed NCT00318266
NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers. No drug interventions Not Available Not Available completed NCT06152666
Day-case Endourology; Enablers, Barriers, Unexpected Outcomes No drug interventions Not Available Not Available recruiting NCT04601766
A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets No drug interventions treatment 1 completed NCT01215266
Sorafenib in Urothelium Cancer of Bladder treatment 2 terminated NCT00004065
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer treatment 1 completed NCT01008865
A Comparison of the Studer Pouch Versus the T-Pouch Orthotopic Neobladder Urinary Diversion in Bladder Cancer Patients No drug interventions treatment Not Available completed NCT00003565
Docetaxel in Treating Patients With Solid Tumors treatment 2 completed NCT01224665
S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer No drug interventions treatment Not Available completed NCT02576665
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) treatment 1 terminated NCT02043665
CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200) treatment 1 completed NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT04770974
Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic No drug interventions Not Available Not Available unknown_status NCT02885974
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer treatment 1 active_not_recruiting NCT06388720
The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy treatment 2 recruiting NCT00002520
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer other Not Available completed NCT02070120
Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer treatment 2 unknown_status NCT03413982
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers No drug interventions Not Available Not Available recruiting NCT03224182
A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) No drug interventions treatment 3 terminated NCT03621982
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors treatment 1 terminated NCT05453682
Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM) No drug interventions treatment Not Available recruiting NCT03789682
CD155 in Bladder Cancer No drug interventions Not Available Not Available recruiting NCT06470282
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer treatment 1 / 2 not_yet_recruiting NCT02324582
MK-3475/BCG in High Risk Superficial Bladder Cancer treatment 1 completed NCT05376631
Effect of Fresh Gas Flow on Emergence Time No drug interventions other Not Available completed NCT04525131
Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors No drug interventions treatment 2 completed NCT05630131
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy No drug interventions Not Available Not Available active_not_recruiting NCT04167631
Can VI-RADS/ADC Accurately Stage Bladder Cancer?? No drug interventions diagnostic Not Available active_not_recruiting NCT03325231
Factors Influencing Patient Choice of Bladder Reconstruction Following Radical Cystectomy No drug interventions Not Available Not Available completed NCT04887831
Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab treatment 2 terminated NCT05415631
Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence No drug interventions Not Available Not Available recruiting NCT04838873
Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center No drug interventions treatment Not Available completed NCT01954173
Adjuvant Radiation for High Risk Bladder Cancer No drug interventions treatment Not Available terminated NCT05016973
A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer treatment 2 not_yet_recruiting NCT02738827
Diode Laser Treatment of Bladder Tumors No drug interventions treatment Not Available completed NCT03134027
Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers No drug interventions Not Available Not Available terminated NCT00848627
Screening for Bladder Cancer No drug interventions Not Available Not Available completed NCT00565227
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. treatment 1 terminated NCT06072027
EVALUATION OF THE REAL-LIFE CONTRIBUTION OF VISIOCYT® BLADDER CYTOLOGY IN PATIENTS WITH SUSPECTED BLADDER TUMOR OR IN THE FOLLOW-UP OF A BLADDER TUMOR No drug interventions diagnostic Not Available not_yet_recruiting NCT05905276
Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT No drug interventions treatment Not Available active_not_recruiting NCT00900276
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants No drug interventions Not Available Not Available completed NCT04570176
Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System No drug interventions treatment Not Available completed NCT00003376
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium treatment 3 completed NCT02880176
Steps to Eliminate Postoperative Problems No drug interventions prevention Not Available completed NCT00028860
Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer treatment 2 completed NCT03125460
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer No drug interventions Not Available Not Available completed NCT04046094
Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients treatment 1 / 2 active_not_recruiting NCT05153694
Infectious Complications After Cystectomy: A Prospective Observational Study No drug interventions Not Available Not Available recruiting NCT03914794
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors treatment 2 recruiting NCT03397394
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma treatment 2 terminated NCT04768894
Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates No drug interventions prevention Not Available completed NCT05400291
Gag-layer in the Urothelium of the Human Upper Urinary Tract No drug interventions Not Available Not Available completed NCT04713891
A Study of KF-0210 in Advanced Solid Tumors Patients treatment 1 unknown_status NCT00461591
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) treatment 3 completed NCT00335491
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors No drug interventions supportive_care Not Available completed NCT02217891
IFACT: Incidental Findings in Advanced Cancer Therapy No drug interventions Not Available Not Available completed NCT05562791
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer No drug interventions diagnostic 1 recruiting NCT02966691
Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors No drug interventions diagnostic Not Available completed NCT04149691
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT04966962
Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics No drug interventions Not Available Not Available unknown_status NCT03289962
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors treatment 1 active_not_recruiting NCT02053662
Biomarker Identification for Bladder Cancer Patients No drug interventions Not Available Not Available unknown_status NCT04593862
Bladder Cancer and exeRcise Training During intraVesical thErapy No drug interventions other 2 recruiting NCT02149862
FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors No drug interventions diagnostic Not Available completed NCT01567462
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors No drug interventions diagnostic Not Available completed NCT02662062
Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer treatment 2 active_not_recruiting NCT00801762
Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology No drug interventions Not Available Not Available completed NCT04311580
Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure treatment 2 completed NCT00490880
Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer treatment 2 completed NCT06281080
First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours No drug interventions treatment Not Available not_yet_recruiting NCT04475029
Methadone in Cystectomy Patients treatment Not Available completed NCT02379429
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue No drug interventions Not Available Not Available recruiting NCT00805129
Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium treatment 2 completed NCT01000129
Adaptive Planning in Bladder Cancer No drug interventions treatment 2 unknown_status NCT00380029
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer treatment 2 completed NCT06022029
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. treatment 1 recruiting NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT01824329
Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer No drug interventions treatment 2 completed NCT05018429
Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male No drug interventions Not Available Not Available unknown_status NCT04839029
Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT No drug interventions treatment Not Available unknown_status NCT06026189
Safely Reduce Cystoscopic Evaluations for Hematuria Patients No drug interventions diagnostic Not Available recruiting NCT04493489
Propranolol Adjuvant Treatment of Bladder Cancer treatment 2 not_yet_recruiting NCT05220189
PENK Methylation Test for Detecting Bladder Cancer No drug interventions Not Available Not Available recruiting NCT00421889
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment treatment 1 / 2 completed NCT04209192
Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB) prevention 2 completed NCT02792192
Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants treatment 1 / 2 terminated NCT01191892
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer treatment 2 completed NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT02465892
Pillars4Life Trial No drug interventions supportive_care Not Available completed NCT00014144
S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract treatment 2 completed NCT05704244
Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC) treatment 3 recruiting NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT01801644
Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer treatment Not Available completed NCT02443844
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression treatment 4 unknown_status NCT00588640
Study of D-Methadone in Patients With Chronic Pain treatment 1 / 2 completed NCT04166240
Measuring and Improving the Safety of Test Result Follow-Up No drug interventions health_services_research Not Available completed NCT04280640
Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes No drug interventions Not Available Not Available withdrawn NCT04934540
The Global En Bloc Resection of Bladder Tumour Registry No drug interventions Not Available Not Available recruiting NCT04464967
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers treatment 1 / 2 withdrawn NCT01542567
Efficacy of Diclofenac BCG Irrigations No drug interventions prevention 3 unknown_status NCT05033067
The Personal Patient Profile Decision Support for Patients With Bladder Cancer No drug interventions supportive_care Not Available recruiting NCT05837767
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue No drug interventions treatment Not Available recruiting NCT03138967
Investigation of Sugammadex in Outpatient Urological Procedures supportive_care 4 completed NCT02846467
Information Improvement for Surgical Patients Through Portable Video Media No drug interventions supportive_care Not Available completed NCT03362801
SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly No drug interventions diagnostic Not Available recruiting NCT02788201
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma No drug interventions treatment 2 completed NCT04712201
En Bloc Bladder Tumor Resection: Prospective Randomized Study No drug interventions diagnostic Not Available recruiting NCT00003701
Combination Chemotherapy in Treating Patients With Bladder Cancer treatment 3 completed NCT05067101
Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men With Bladder Cancer No drug interventions treatment Not Available recruiting NCT04985604
Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors treatment 1 / 2 recruiting NCT03534804
Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma treatment 2 active_not_recruiting NCT02841904
The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder Neoplasia No drug interventions diagnostic Not Available unknown_status NCT02572804
Comparing Rectus Sheath Catheter to Epidural Post Cystectomy No drug interventions treatment Not Available unknown_status NCT03052504
Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy No drug interventions Not Available Not Available completed NCT02015104
Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG No drug interventions treatment 2 completed NCT05885204
RARC vs LRC in A Multicenter Cohort Study No drug interventions Not Available Not Available not_yet_recruiting NCT03662204
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors No drug interventions Not Available Not Available completed NCT04162704
EpiCheck and Short-term Intensive Chemoresection in NMIBC No drug interventions Not Available Not Available unknown_status NCT01498172
BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients treatment 1 completed NCT05052372
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib Not Available Not Available terminated NCT04588168
Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma No drug interventions diagnostic Not Available recruiting NCT00859768
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients No drug interventions supportive_care Not Available completed NCT00959868
A Study for Treatment of Superficial Bladder Cancer Using OGX-427 treatment 1 unknown_status NCT03121768
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) No drug interventions Not Available Not Available unknown_status NCT06046469
Validity of Computed Tomography Versus Magnetic Resonance Imaging in Predicting Muscular Invasion of Bladder Cancer No drug interventions diagnostic Not Available recruiting NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors No drug interventions treatment 1 recruiting NCT06310369
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer No drug interventions treatment 2 not_yet_recruiting NCT02609269
Decipher Genomics Resource for Intelligent Discovery No drug interventions Not Available Not Available enrolling_by_invitation NCT01812369
Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer treatment 3 unknown_status NCT00088946
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer treatment 2 completed NCT02188446
Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients No drug interventions prevention Not Available completed NCT04219046
Evaluation of Naloxegol in the Prevention of POI After Cystectomy treatment 2 unknown_status NCT03505112
The Effect of Goal-directed Hemodynamic Therapy in Radical Cystectomy No drug interventions prevention Not Available completed NCT01711112
Salvage Docetaxel for Pretreated Urothelial Cancer treatment 2 completed NCT00066612
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy treatment 2 completed NCT05739812
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery No drug interventions other Not Available recruiting NCT06136312
Clinical Investigation of the Multi4 System No drug interventions treatment Not Available not_yet_recruiting NCT04603612
The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor. No drug interventions diagnostic Not Available completed NCT02647112
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma No drug interventions diagnostic Not Available completed NCT01438112
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer treatment 2 / 3 terminated NCT03174912
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? No drug interventions treatment 4 completed NCT03066310
Urine-DNA Biomarkers in Detecting Bladder Cancer No drug interventions Not Available Not Available completed NCT04383210
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors treatment 2 active_not_recruiting NCT02039310
Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy No drug interventions Not Available Not Available completed NCT04543110
Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC treatment 2 recruiting NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease No drug interventions Not Available Not Available recruiting NCT04564781
Predicting BCG Response No drug interventions Not Available Not Available recruiting NCT00080795
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium treatment 2 completed NCT06381895
The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer No drug interventions Not Available Not Available completed NCT06374914
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients Not Available Not Available not_yet_recruiting NCT06157814
Mobile Ostomates Resources for Patients and Caregivers No drug interventions other Not Available active_not_recruiting NCT00579514
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients No drug interventions screening Not Available active_not_recruiting NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications treatment 1 recruiting NCT03693014
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors treatment 2 recruiting NCT00003814
Eflornithine in Treating Patients With Bladder Cancer treatment 3 completed NCT02903914
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors treatment 1 / 2 completed NCT04209114
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer treatment 3 completed NCT00389155
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy treatment 2 / 3 completed NCT05937555
Professional Bladder Cancers and the Profession of Painter No drug interventions Not Available Not Available completed NCT02346955
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) treatment 1 terminated NCT05231655
Ex VIvo DEtermiNed Cancer Therapy No drug interventions Not Available Not Available recruiting NCT00745355
Quality of Life in Patients With Bladder Cancer No drug interventions Not Available Not Available active_not_recruiting NCT01108055
Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer treatment 2 completed NCT05055050
A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 treatment 1 suspended NCT00268450
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery treatment 2 terminated NCT01104350
Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy No drug interventions treatment 1 active_not_recruiting NCT00516750
Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin treatment 2 terminated NCT00003623
High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer No drug interventions prevention 3 completed NCT05290623
High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT00001823
Evaluation for NCI Surgery Branch Clinical Research Protocols No drug interventions Not Available Not Available recruiting NCT05810623
Single-Dose Intravesical Chemotherapy After Diagnostic URS No drug interventions prevention 3 not_yet_recruiting NCT00004223
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer treatment 2 completed NCT05204108
Preoperative Detection of Muscle Invasion in Bladder Cancer With Contrast-enhanced Ultrasonography No drug interventions Not Available Not Available unknown_status NCT00918008
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer No drug interventions Not Available Not Available terminated NCT00101608
Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium treatment 2 completed NCT00365508
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking treatment 4 completed NCT06571708
A Study of Gemcitabine/Cisplatin Plus Cemiplimab (REGN2810, Anti-PD-1) With or Without Fianlimab (REGN3767, Anti-LAG-3) in Patients With Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) treatment 2 not_yet_recruiting NCT01955408
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment No drug interventions Not Available Not Available completed NCT00147238
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast No drug interventions treatment Not Available terminated NCT06548438
The Impact of PDD During TURB for NMIBC No drug interventions diagnostic 4 not_yet_recruiting NCT00609843
Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer No drug interventions diagnostic Not Available completed NCT02643043
UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch No drug interventions other Not Available completed NCT05375903
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) treatment 1 recruiting NCT00004203
Oxaliplatin in Treating Patients With Metastatic Bladder Cancer treatment 2 completed NCT02643303
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers treatment 1 / 2 completed NCT04750590
Relationship Between Methods of Bladder Tumor Extraction and Local Recurrence Rate No drug interventions treatment Not Available unknown_status NCT00902590
A Genotype-Phenotype Urothelial Cancer Registry No drug interventions Not Available Not Available active_not_recruiting NCT06528990
Telehealth Intervention for Ostomy Self-Management No drug interventions supportive_care 2 not_yet_recruiting NCT00002490
Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer treatment 3 completed NCT04235764
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device No drug interventions Not Available Not Available recruiting NCT02942121
Application-based Perioperative Management of the Radical Cystectomy Patient No drug interventions prevention Not Available completed NCT03837821
(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer treatment 0 recruiting NCT04537221
Nordic Cystectomy Study III - Transfusion No drug interventions Not Available Not Available recruiting NCT02695121
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment No drug interventions Not Available Not Available recruiting NCT00634621
Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer Not Available Not Available completed NCT03831321
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy supportive_care 4 unknown_status NCT02552121
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT00233402
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy Not Available 3 completed NCT04368702
CONFIRM: Magnetic Resonance Guided Radiation Therapy No drug interventions treatment Not Available recruiting NCT04718584
the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors No drug interventions treatment 2 unknown_status NCT04756284
Evaluation of the PhageTech Virus BioResistor No drug interventions Not Available Not Available unknown_status NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT00696579
Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer treatment 1 / 2 completed NCT00352079
BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer treatment 3 terminated NCT03558087
Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing treatment 2 completed NCT00376987
Zinc Supplements in Lowering Cadmium Levels in Smokers No drug interventions prevention 2 completed NCT02785887
Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients No drug interventions health_services_research Not Available completed NCT03962933
Urine-based Detection of Non-muscle Invasive Bladder No drug interventions Not Available Not Available completed NCT00003133
Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer treatment 1 completed NCT00022633
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract treatment 2 terminated NCT05096533
The Application Value of Artificial Intelligence in MRI Precision Diagnosis and Treatment of Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT02925533
Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract treatment 1 terminated NCT00802633
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device? No drug interventions treatment Not Available terminated NCT04579133
Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy treatment 2 terminated NCT06294054
Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy No drug interventions Not Available Not Available active_not_recruiting NCT00303654
Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection No drug interventions treatment Not Available completed NCT00871754
Molecular Analysis Of Bladder Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT06020651
Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside No drug interventions basic_science Not Available recruiting NCT03212651
Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab treatment 2 completed NCT00461851
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma treatment 2 completed NCT03454451
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers treatment 1 completed NCT01459653
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor No drug interventions Not Available Not Available completed NCT05253053
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT05879653
Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD) treatment 2 recruiting NCT00315653
Survivin Urine mRNA Assay Risk of Bladder Cancer Study No drug interventions Not Available Not Available completed NCT04583553
Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture No drug interventions Not Available Not Available unknown_status NCT04972253
Phase I BLASST-3 Trial treatment 1 withdrawn NCT06235853
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT01236053
Cancer in Patients With Gabapentin (GPRD) Not Available Not Available completed NCT02422277
Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy treatment 2 unknown_status NCT05512377
Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder treatment 2 recruiting NCT05108077
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells No drug interventions treatment 1 / 2 unknown_status NCT04148677
Protoves M1® Syrup in Controlling Adverse Event During HIVEC® Instillations No drug interventions Not Available Not Available unknown_status NCT04503577
Prospective Bladder Cancer Infrastructure (ProBCI) No drug interventions Not Available Not Available recruiting NCT04036877
Mood Disorders Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT00867347
Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer No drug interventions treatment 3 completed NCT00005047
4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer treatment 3 terminated NCT06059547
Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer treatment 2 recruiting NCT00938145
3 Tesla MRI in Patients With Bladder Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT01810445
Endoscopic Subsurface Optical Imaging for Cancer Detection No drug interventions Not Available Not Available completed NCT02543645
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer treatment 1 terminated NCT01655745
Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer No drug interventions diagnostic Not Available completed NCT05524545
A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07) treatment 1 recruiting NCT04314245
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma No drug interventions Not Available Not Available completed NCT01684098
Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor No drug interventions other 2 completed NCT00694798
Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder No drug interventions treatment 1 completed NCT05144698
RAPA-201 Therapy of Solid Tumors treatment 1 / 2 recruiting NCT05136898
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC) treatment 3 completed NCT02298998
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study No drug interventions Not Available Not Available completed NCT01373398
Safety and Pharmacokinetic Study of EO9(Intravesical Instillation) Not Available 1 completed NCT03385798
Endo-GIA Versus Endowrist Stapler in Intracorporeal Urinary Diversion in Robotic Assisted Radical Cystectomy No drug interventions treatment Not Available completed NCT00003105
Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer treatment 1 / 2 completed NCT00244205
Identifying Methylation Biomarkers for Monitoring Bladder Tumors No drug interventions Not Available Not Available unknown_status NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study No drug interventions Not Available Not Available recruiting NCT02197897
Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors treatment 2 completed NCT05259397
PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) treatment 1 withdrawn NCT01087697
Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit No drug interventions treatment 1 completed NCT06528483
Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer treatment 2 not_yet_recruiting NCT02716961
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer treatment Not Available unknown_status NCT05982561
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer No drug interventions Not Available Not Available recruiting NCT00341861
Interdisciplinary Case-Control Study of Bladder Cancer in Spain No drug interventions Not Available Not Available completed NCT03762161
A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer No drug interventions treatment 2 unknown_status NCT02563561
A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT) treatment 3 terminated NCT02625961
Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057) treatment 2 recruiting NCT03863028
Development and Validation of a Simulator-based Test in Transurethral Resection of Bladder Tumors No drug interventions Not Available Not Available completed NCT02109328
Alisertib in Chemotherapy-pretreated Urothelial Cancer treatment 2 completed NCT03556228
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma treatment 1 recruiting NCT03291028
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma No drug interventions Not Available Not Available recruiting NCT03193528
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer No drug interventions Not Available Not Available recruiting NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Not Available Not Available available NCT03257293
A Trial of a Modified Cystoscopy Method to Reduce Pain Perception No drug interventions supportive_care Not Available completed NCT04162093
New Technique for Uretero-ileal Anastomosis for Patient With Bladder Cancer Who Are Suitable for Orthotopic Neobladder No drug interventions treatment Not Available completed NCT05273593
Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and Treatment No drug interventions diagnostic Not Available completed NCT06427993
Urine DNA Methylation Detection for Hematuria Evaluation No drug interventions Not Available Not Available not_yet_recruiting NCT02145871
A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy No drug interventions treatment 3 completed NCT01215071
Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA No drug interventions treatment Not Available completed NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers treatment 1 recruiting NCT05739071
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer No drug interventions treatment Not Available enrolling_by_invitation NCT03007771
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia No drug interventions device_feasibility 1 withdrawn NCT06525571
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection other 3 not_yet_recruiting NCT02951078
A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer No drug interventions treatment 3 unknown_status NCT04314778
Using Patient Centered Data and Behavioral Economics to Improve Mobility and Reduce Readmissions After Major Abdominal Surgery No drug interventions other Not Available completed NCT02648178
Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers No drug interventions other Not Available completed NCT03915678
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors treatment 2 recruiting NCT00084578
Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder treatment Not Available withdrawn NCT01180478
Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer No drug interventions treatment Not Available completed NCT03689478
Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT No drug interventions treatment Not Available completed NCT00350688
Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy No drug interventions treatment Not Available terminated NCT03193788
Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy treatment 3 unknown_status NCT05200988
Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC treatment 2 active_not_recruiting NCT01089088
Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) treatment 2 completed NCT00995488
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer treatment 2 terminated NCT02365207
Intravesical BCG Administration to Patients With Invasive Bladder Cancer treatment Not Available terminated NCT03474107
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) treatment 3 active_not_recruiting NCT05568407
A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer Not Available Not Available terminated NCT01551407
Detection of Bladder Tumors After 30 Min Instillation of Hexvix diagnostic 2 terminated NCT03756207
Multidisciplinary Bladder-preservation Therapy for Bladder Cancer No drug interventions treatment Not Available unknown_status NCT00544609
Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent treatment 1 completed NCT00053209
Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium treatment 2 completed NCT03379909
Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer treatment 2 recruiting NCT05939856
Lymph Node Dissection Before Or After Cystectomy No drug interventions treatment Not Available recruiting NCT04235556
Integrated Care Pathway in Oncology (PASSION) No drug interventions Not Available Not Available unknown_status NCT04979156
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors No drug interventions Not Available Not Available unknown_status NCT00526656
Sunitinib in Treating Patients With Locally Advanced Bladder Cancer treatment 2 completed NCT05799456
Glycosaminoglycan Scores as Early Detection Biomarkers in Bladder Urothelial Carcinoma No drug interventions Not Available Not Available completed NCT03740256
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors No drug interventions treatment 1 recruiting NCT06167356
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. No drug interventions Not Available Not Available recruiting NCT05646485
Bladder Cancer Screening Trial No drug interventions screening Not Available recruiting NCT02174185
Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic Neobladders No drug interventions Not Available Not Available unknown_status NCT01663285
Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) treatment 2 terminated NCT00553215
Quality of Life in Patients With Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT00310115
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy No drug interventions Not Available Not Available completed NCT03193515
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00694915
Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder No drug interventions treatment 2 completed NCT05344937
Validation Study of Uromonitor in High Risk Microhematuria Patients No drug interventions Not Available Not Available unknown_status NCT00315237
Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract treatment 3 completed NCT00016237
Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment treatment 1 completed NCT05061537
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors treatment 1 terminated NCT03138837
Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage No drug interventions Not Available Not Available unknown_status NCT02756637
Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710 No drug interventions Not Available Not Available completed NCT04167332
Prospective Collection of Samples for Urothelial Cancer of Bladder No drug interventions Not Available Not Available not_yet_recruiting NCT00471432
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors treatment 1 completed NCT03464032
A Study of BCD-135 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00962052
Biomarker Discovery and Application in Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT02811952
Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients No drug interventions Not Available Not Available completed NCT06341400
RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients treatment 1 / 2 recruiting NCT03307200
Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical Cystectomy No drug interventions Not Available Not Available completed NCT03125200
Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression treatment 1 terminated NCT04900259
The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations No drug interventions Not Available Not Available completed NCT03584659
Patient-reported Outcomes in Bladder Cancer No drug interventions supportive_care Not Available completed NCT01698359
Evaluation of Ultrasound Probe for Use in Bladder Radiotherapy No drug interventions Not Available Not Available unknown_status NCT04966975
Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy No drug interventions Not Available Not Available unknown_status NCT03768570
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer treatment 2 active_not_recruiting NCT04412070
Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients No drug interventions Not Available Not Available active_not_recruiting NCT06394570
Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer treatment 1 / 2 not_yet_recruiting NCT05347342
A Diagnostic for the Early Detection of Bladder Cancer No drug interventions Not Available Not Available recruiting NCT02553642
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) treatment 2 completed NCT00003642
Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer treatment 2 terminated NCT02233842
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors No drug interventions Not Available Not Available completed NCT03892642
Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer treatment 1 / 2 completed NCT00003342
Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer treatment 1 completed NCT02345499
Open Versus Laparoscopic Radical Cystectomy No drug interventions supportive_care 2 unknown_status NCT01170299
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer No drug interventions supportive_care Not Available completed NCT03286699
Lifestyle Change for Better Health No drug interventions supportive_care Not Available active_not_recruiting NCT05824299
Influence of Anesthesia Methods on CTCs in TURBT Patients No drug interventions health_services_research Not Available not_yet_recruiting NCT06358599
The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy Not Available Not Available completed NCT02012699
Integrated Cancer Repository for Cancer Research No drug interventions Not Available Not Available recruiting NCT03796299
Expression of MCM5 in Urine in Patients With Urothelial Cancers No drug interventions Not Available Not Available unknown_status NCT06334406
Antitumor T Cell Responses in Patients With Bladder Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT04532606
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery prevention 4 recruiting NCT00598806
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) treatment 3 completed NCT02447549
Study of Tumour Focused Radiotherapy for Bladder Cancer No drug interventions treatment 2 active_not_recruiting NCT00002949
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis treatment 1 completed NCT00024349
Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer treatment 3 completed NCT00199849
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine treatment 1 completed NCT04966949
Lateral Prostate Capsule Sparing Versus Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male No drug interventions treatment Not Available unknown_status NCT06153849
Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup No drug interventions Not Available Not Available not_yet_recruiting NCT04872036
Prognostic Biomarkers in Patients With Urothelial Carcinoma No drug interventions Not Available Not Available completed NCT03150836
Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer treatment 2 withdrawn NCT00033436
Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer treatment 3 completed NCT03245736
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. treatment 2 completed NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT04186013
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer treatment 2 active_not_recruiting NCT02360618
Metformin and Simvastatin Use in Bladder Cancer treatment 2 unknown_status NCT04701918
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma treatment 2 recruiting NCT05082818
Outcome of Treating Bladder Cancer in Sohag University Hospital No drug interventions Not Available Not Available completed NCT00772018
Quality of Life and Symptom Management in Patients With Bladder Cancer No drug interventions Not Available Not Available completed NCT04245618
Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer Not Available Not Available unknown_status NCT00011518
Bladder Cancer Case Control Study of Arsenic in Water No drug interventions Not Available Not Available completed NCT02365818
Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure treatment 2 completed NCT00974818
Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients treatment 3 terminated NCT01442519
Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer treatment 3 completed NCT00082719
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium treatment 1 completed NCT06116019
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) No drug interventions Not Available Not Available recruiting NCT06416319
Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) No drug interventions treatment Not Available recruiting NCT00002919
Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer treatment 2 completed NCT05151341
Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors No drug interventions diagnostic Not Available recruiting NCT03193541
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer No drug interventions Not Available Not Available recruiting NCT03232541
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting No drug interventions supportive_care Not Available recruiting NCT04424641
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors No drug interventions treatment 1 / 2 terminated NCT02074241
Molecular Markers of Chemosensitivity for Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT02869217
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors treatment 1 active_not_recruiting NCT04825834
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) No drug interventions Not Available Not Available recruiting NCT00006034
Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer treatment 3 completed NCT05219734
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment No drug interventions Not Available Not Available active_not_recruiting NCT03822234
A Clinical Trial of Extraperitonealization for Prevention of Parastomal Hernia After Ileal Conduit No drug interventions prevention Not Available completed NCT01496534
Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors treatment 1 terminated NCT01010334
Comparison of Standard of Care or Treatment on Protocol No drug interventions Not Available Not Available terminated NCT05179824
Tempus Priority Study: A Pan-tumor Observational Study No drug interventions Not Available Not Available recruiting NCT06119724
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors No drug interventions treatment Not Available active_not_recruiting NCT00553124
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer prevention 3 unknown_status NCT06427824
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy No drug interventions other Not Available recruiting NCT04273724
Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer No drug interventions supportive_care Not Available terminated NCT01240824
Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer Not Available 0 completed NCT06357416
The Man Van Project No drug interventions diagnostic Not Available recruiting NCT02505516
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS No drug interventions screening 0 completed NCT06005116
[68Ga] NOTA-SGC8 in the Staging of Bladder Cancer No drug interventions diagnostic Not Available recruiting NCT04385316
Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy No drug interventions Not Available Not Available unknown_status NCT02106416
Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development No drug interventions diagnostic Not Available completed NCT01563796
Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT01094496
A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study) No drug interventions treatment 2 terminated NCT03081858
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer treatment 1 / 2 completed NCT02690558
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy treatment 2 active_not_recruiting NCT04900558
Robotic Radical Cystectomy Outcomes No drug interventions Not Available Not Available recruiting NCT03317158
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder treatment 1 / 2 recruiting NCT03148158
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident No drug interventions Not Available Not Available unknown_status NCT03298958
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer treatment 3 withdrawn NCT01637935
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes Not Available Not Available completed NCT03799835
Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients treatment 3 active_not_recruiting NCT02628535
Safety Study of MGD009 in B7-H3-expressing Tumors No drug interventions treatment 1 terminated NCT05656235
Renal Retention in High Grade Upper Tract Urothelial Cancer treatment 2 not_yet_recruiting NCT04726735
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT05146635
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial treatment Not Available unknown_status NCT05699135
A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer Not Available Not Available terminated NCT02555163
Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT) No drug interventions treatment Not Available completed NCT03029663
Complications of Transurethral Resection of the Bladder Tumour No drug interventions Not Available Not Available completed NCT02605863
Enzalutamide for Bladder Cancer Chemoprevention prevention 2 terminated NCT05001763
Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy treatment 2 unknown_status NCT04200963
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma treatment 1 completed NCT03504163
Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)] treatment 2 recruiting NCT04319263
Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer No drug interventions treatment Not Available completed NCT05726786
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) No drug interventions supportive_care 3 recruiting NCT00005086
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer treatment 2 completed NCT02657486
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder treatment Not Available active_not_recruiting NCT05084586
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation treatment Not Available recruiting NCT00234039
S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin treatment 2 completed NCT05362539
Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria No drug interventions diagnostic Not Available completed NCT04994639
Hypotension Prediction Effect on AKI No drug interventions prevention Not Available completed NCT00756639
Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium No drug interventions treatment 2 active_not_recruiting NCT04553939
Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer treatment 2 unknown_status NCT05792722
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy No drug interventions treatment Not Available recruiting NCT05120622
Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer treatment 1 / 2 withdrawn NCT02186925
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. No drug interventions Not Available Not Available recruiting NCT00003725
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer treatment 3 unknown_status NCT04040725
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression treatment 2 withdrawn NCT05184725
CARINAE for Stress Relief in Perioperative Care No drug interventions treatment Not Available completed NCT04523025
Nordic Cystectomy Study I - Neutrophil-lymphocyte Ratio (NLR) No drug interventions Not Available Not Available recruiting NCT03216525
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol treatment 3 recruiting NCT04305730
Use of Pedometer Following Radical Cystectomy No drug interventions other Not Available unknown_status NCT04630730
Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC treatment 2 recruiting NCT04738630
Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer treatment 2 unknown_status NCT03852030
Mind-Body Health in Uro-Oncology: Research Study No drug interventions supportive_care Not Available completed NCT02092948
Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer No drug interventions diagnostic 1 completed NCT01284348
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer supportive_care 2 terminated NCT02887248
Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma treatment 2 terminated NCT00714948
Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma treatment 2 terminated NCT02901548
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder treatment 2 terminated NCT04487457
Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy No drug interventions Not Available Not Available completed NCT00003657
High-dose ICE With Amifostine treatment 2 completed NCT03058757
The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation prevention 2 completed NCT03933826
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05714826
Comprehensive Optimization At-time of Radical Cystectomy Intervention No drug interventions prevention Not Available recruiting NCT00054626
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer treatment 3 unknown_status NCT04334226
The Impact of Preoperative Urostomy Education on Patients and Families No drug interventions Not Available Not Available completed NCT01475266
Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) treatment 2 / 3 terminated NCT02365766
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects treatment 1 / 2 active_not_recruiting NCT05429866
Immunological Variables Associated to ICI Toxicity in Cancer Patients other 2 recruiting NCT02662166
MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer No drug interventions diagnostic Not Available completed NCT01090466
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium treatment 1 / 2 completed NCT00553566
Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT01410565
Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer treatment 3 terminated NCT01826565
Comparison of Two Insertion Technique of I-gel No drug interventions treatment Not Available unknown_status NCT01276665
Effects of Noradrenaline Administration Combined With Restrictive Intraoperative Fluid Substitution on Perioperative Outcome in Patients Undergoing Radical Cystectomy No drug interventions treatment Not Available completed NCT05846165
InveStigAting Bladder fiELd-cycLing imAging No drug interventions basic_science Not Available not_yet_recruiting NCT06227065
Precise Neoadjuvant Chemoresection of Low Grade NMIBC treatment 2 not_yet_recruiting NCT01316874
Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) treatment 2 / 3 completed NCT00014274
Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium treatment 2 / 3 completed NCT03472274
Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO) treatment 2 completed NCT02030574
Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin treatment 2 terminated NCT00933374
Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma treatment 2 terminated NCT00246974
Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT treatment 2 completed NCT00829920
The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease No drug interventions Not Available Not Available completed NCT00867620
Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma No drug interventions Not Available Not Available unknown_status NCT01124682
3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder No drug interventions treatment 1 unknown_status NCT04688931
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer treatment 3 terminated NCT03520231
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases treatment 2 completed NCT05779631
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm No drug interventions diagnostic Not Available recruiting NCT02800473
Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection No drug interventions other Not Available completed NCT02345473
Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy No drug interventions Not Available Not Available completed NCT00622973
USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases No drug interventions diagnostic 3 completed NCT05819827
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics No drug interventions Not Available Not Available recruiting NCT03934827
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour treatment 1 unknown_status NCT00006476
Suramin in Treating Patients With Recurrent Bladder Cancer treatment 1 completed NCT04282876
Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer Not Available Not Available recruiting NCT01222676
Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder treatment 2 unknown_status NCT00006376
R115777 in Treating Patients With Advanced Bladder Cancer treatment 2 completed NCT00146276
Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer treatment 3 unknown_status NCT03960060
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors No drug interventions treatment 1 unknown_status NCT01622660
Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy treatment 2 terminated NCT06537960
Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers No drug interventions diagnostic Not Available recruiting NCT04073160
TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer treatment 1 withdrawn NCT03715660
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study No drug interventions diagnostic Not Available completed NCT04574960
Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) treatment 3 recruiting NCT01589094
Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer treatment 2 completed NCT01373294
Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer treatment 2 completed NCT04939194
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. No drug interventions treatment 3 unknown_status NCT00785694
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix diagnostic 4 withdrawn NCT00234494
Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer treatment 2 completed NCT06253091
Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy No drug interventions treatment Not Available recruiting NCT00022191
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer treatment 3 completed NCT03520491
A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy treatment 2 recruiting NCT06337591
Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location No drug interventions Not Available Not Available completed NCT00777491
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery treatment 2 completed NCT00978991
Duke Urology Database and Specimen Bank No drug interventions Not Available Not Available completed NCT06427291
Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients treatment 1 recruiting NCT06040762
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial No drug interventions supportive_care Not Available recruiting NCT05397262
Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia treatment Not Available recruiting NCT03469362
Intracorporeal vs Extracorporeal Urinary Diversion After Robot Assisted Radical Cystectomy No drug interventions other Not Available active_not_recruiting NCT00709462
A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) No drug interventions treatment 1 completed NCT05137262
A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder treatment 2 recruiting NCT02676180
Detecting Bladder Cancer Using the UroMark Test. No drug interventions Not Available Not Available completed NCT06469229
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria No drug interventions Not Available Not Available not_yet_recruiting NCT00003129
Chemotherapy in Treating Patients With Early-Stage Bladder Cancer treatment 2 completed NCT02675829
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers treatment 2 recruiting NCT03409029
A Study Using MRI To Assess Bladder Motion During Radiotherapy No drug interventions basic_science Not Available unknown_status NCT00479089
Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer treatment 2 terminated NCT00848289
Genetic Susceptibility to Bladder Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04779489
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer No drug interventions treatment Not Available terminated NCT00585689
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer treatment 2 completed NCT04316689
First-in-human Study of S-588210 (S-488210+S-488211) No drug interventions treatment 1 completed NCT02074189
Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer treatment 3 unknown_status NCT00095589
Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer No drug interventions Not Available Not Available completed NCT05337189
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China No drug interventions Not Available Not Available recruiting NCT05671289
Urine VOC Investigation in Bladder Cancer Diagnosis No drug interventions Not Available Not Available completed NCT05462392
Robot-assisted Urological Surgeries Using the MicroHand S Robot No drug interventions other Not Available recruiting NCT01918592
PET/MRI and Biomarkers in Bladder Cancer No drug interventions diagnostic Not Available completed NCT03534492
Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB) treatment 2 completed NCT00744744
Health-Related Quality of Life in Patients With Bladder Cancer No drug interventions Not Available Not Available completed NCT00005644
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function treatment 2 completed NCT03156244
Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients No drug interventions Not Available Not Available completed NCT02400944
Determinants of Bladder Cancer Recurrence Study (The DETER Study) No drug interventions Not Available Not Available active_not_recruiting NCT02452944
Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve Block No drug interventions Not Available Not Available completed NCT06443944
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG Not Available Not Available available NCT06397040
The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy No drug interventions supportive_care Not Available not_yet_recruiting NCT00003640
Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer treatment 2 terminated NCT06305767
A Study of Pembrolizumab (MK-3475) Plus V940 in Participants With Bladder Cancer Post-Radical Resection (V940-005) treatment 2 recruiting NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) No drug interventions treatment Not Available recruiting NCT03591367
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation No drug interventions diagnostic Not Available completed NCT02951767
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1) treatment 2 completed NCT00445601
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer treatment 3 completed NCT02113501
Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study No drug interventions Not Available Not Available completed NCT06395701
Trimodality Treatment in Bladder Cancer No drug interventions Not Available Not Available recruiting NCT00055601
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer treatment 2 completed NCT02287701
Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization No drug interventions diagnostic Not Available completed NCT00534001
Bupropion in Helping Adults Stop Smoking other 2 completed NCT03914001
Comprehensive Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Non Muscle-invasive Bladder Tumor; Can it Replace Second Look Biopsy? A Prospective Study No drug interventions diagnostic Not Available unknown_status NCT00633204
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer No drug interventions prevention 2 unknown_status NCT02143804
Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer treatment 2 withdrawn NCT06364904
An Phase III Study, Multicenter，Randomized Controlled Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma. treatment 3 not_yet_recruiting NCT05123404
Validation of VI-RADS for the Detection of Detrusor Muscle Invasion No drug interventions diagnostic Not Available unknown_status NCT02999672
A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors treatment 2 completed NCT04970472
Bio Clinical Collection of Urothelial Carcinoma No drug interventions Not Available Not Available recruiting NCT04286672
Metadherin mRNA Expression in Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT04533672
Multiparametric Magnetic Resonance Imaging (MRI) to Improve Bladder Cancer Staging and Treatment Decision-making No drug interventions diagnostic Not Available recruiting NCT01182168
Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies treatment 1 completed NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT02326168
PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer treatment 0 completed NCT05508568
A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer No drug interventions Not Available Not Available recruiting NCT04406168
Assessment of Urinary Diversions Outcomes Post Radical Cystectomy in Asyut University Urology Hospital No drug interventions Not Available Not Available unknown_status NCT03185468
Intervention of Bladder Cancer by CAR-T No drug interventions treatment 1 / 2 unknown_status NCT01087268
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer No drug interventions supportive_care 3 unknown_status NCT05739968
Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients No drug interventions supportive_care Not Available recruiting NCT03664869
Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer treatment 3 recruiting NCT03348969
Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC treatment 4 active_not_recruiting NCT00790569
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking prevention Not Available completed NCT06002269
A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients No drug interventions prevention Not Available recruiting NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection No drug interventions diagnostic 2 not_yet_recruiting NCT04081246
Transurethral Modified En Bloc Resection For Large Bladder Tumours. No drug interventions treatment Not Available recruiting NCT04386746
Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer treatment 2 active_not_recruiting NCT05027412
En Bloc TURBT With Collins Loop vs Conventional TURBT No drug interventions treatment Not Available unknown_status NCT04194112
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study No drug interventions diagnostic Not Available completed NCT06422312
A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. No drug interventions health_services_research Not Available not_yet_recruiting NCT01082510
Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study) treatment 3 unknown_status NCT05102110
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. No drug interventions Not Available Not Available recruiting NCT06032910
Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias No drug interventions treatment Not Available recruiting NCT06243510
Comparison of Apixaban Versus Enoxaparin No drug interventions other Not Available enrolling_by_invitation NCT06009510
Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT00652210
Use of Multiphoton Microscopy in the Diagnosis of Cancer No drug interventions diagnostic 1 completed NCT02300610
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer treatment 1 completed NCT03049410
Trial to Compare Robotically Assisted Radical Cystectomy With Open Radical Cystectomy No drug interventions treatment Not Available unknown_status NCT03106610
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy treatment 1 terminated NCT01700010
Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer treatment 2 withdrawn NCT02655081
Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy No drug interventions basic_science 2 completed NCT02177695
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer treatment 2 completed NCT00087295
S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium treatment 2 terminated NCT00004095
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors treatment 1 completed NCT01042795
Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy treatment 2 terminated NCT02471495
RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE) No drug interventions treatment 3 withdrawn NCT03517995
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention prevention 2 withdrawn NCT02292914
Prospective Analysis of Robot-Assisted Surgery No drug interventions treatment Not Available unknown_status NCT00216814
Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors No drug interventions Not Available Not Available terminated NCT00757614
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom No drug interventions Not Available Not Available unknown_status NCT04197414
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA No drug interventions Not Available Not Available recruiting NCT01688414
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer No drug interventions diagnostic Not Available withdrawn NCT00002914
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract treatment 2 completed NCT00949455
A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium treatment 2 / 3 unknown_status NCT00213655
URO-BCG-4 : Bladder Tumors Immunotherapy No drug interventions Not Available Not Available completed NCT00506155
Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer treatment 2 completed NCT06092450
Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer No drug interventions Not Available Not Available recruiting NCT05344950
Connecting Audio and Radio Sensing Systems to Improve Care at Home No drug interventions Not Available Not Available recruiting NCT03697850
Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy treatment 2 active_not_recruiting NCT02080650
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) No drug interventions device_feasibility Not Available completed NCT05790850
Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial) No drug interventions supportive_care Not Available recruiting NCT05243550
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer treatment 3 active_not_recruiting NCT02845050
Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO) treatment 1 / 2 withdrawn NCT02340650
High Resolution Imaging for Early and Better Detection of Bladder Cancer No drug interventions Not Available Not Available completed NCT03775850
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors treatment 1 completed NCT04878250
Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder treatment 2 not_yet_recruiting NCT02845323
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder treatment 2 active_not_recruiting NCT05112523
The Performance of Cancer Risk Genes in the Necessity of Secondary TURBT No drug interventions Not Available Not Available unknown_status NCT02001623
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT02716623
The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer No drug interventions prevention Not Available completed NCT05531123
Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer treatment 2 recruiting NCT06565923
Study on the Staging and Prognosis Model of Bladder Cancer No drug interventions Not Available Not Available active_not_recruiting NCT06301308
A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial supportive_care 3 withdrawn NCT05871008
Integrated Actionable Aging Assessment for Cancer Patients Pilot No drug interventions health_services_research Not Available recruiting NCT01198808
Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker No drug interventions Not Available Not Available unknown_status NCT01776138
Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer No drug interventions Not Available Not Available completed NCT04383938
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies treatment 1 / 2 completed NCT04523038
Nordic Cystectomy Study II - Albumin No drug interventions Not Available Not Available recruiting NCT06580938
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer treatment 1 not_yet_recruiting NCT03563443
Genomic Imprinting Testing for Diagnosis of Bladder Cancer No drug interventions Not Available Not Available unknown_status NCT02948543
Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer treatment 3 active_not_recruiting NCT01391143
Safety Study of MGA271 in Refractory Cancer treatment 1 completed NCT04958343
Application and Clinical Effectiveness of Pelvic Reconstruction in Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder in the Male No drug interventions Not Available Not Available unknown_status NCT04555343
Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention treatment 1 / 2 completed NCT00318643
Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer prevention 1 / 2 completed NCT02010203
A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT No drug interventions treatment 1 / 2 terminated NCT04212403
Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) prevention Not Available completed NCT03637803
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors treatment 1 / 2 terminated NCT00003103
Chemotherapy in Treating Patients With Solid Tumors treatment 1 / 2 completed NCT03558503
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer treatment 2 completed NCT01196403
Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer No drug interventions treatment 2 unknown_status NCT04916990
Improving Care for Rural Patients With Solid Tumors No drug interventions health_services_research Not Available recruiting NCT03639090
Mass Spectrometry in Single Bladder Cancer Cells No drug interventions Not Available Not Available completed NCT02992990
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade No drug interventions other Not Available unknown_status NCT05643690
Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay No drug interventions Not Available Not Available suspended NCT00002990
Surgery and BCG in Treating Patients With Bladder Cancer treatment 3 completed NCT02660190
Photodynamic Diagnosis (PDD) in Flexible Cystoscopy treatment 3 completed NCT02145390
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy No drug interventions treatment Not Available terminated NCT03869190
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) treatment 1 / 2 recruiting NCT02141490
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers diagnostic 2 completed NCT04391790
MOdified Urinary Conduit to Lower Strictures After radIcal Cystectomy No drug interventions prevention Not Available active_not_recruiting NCT00587964
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases No drug interventions treatment 2 completed NCT02700464
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma No drug interventions diagnostic Not Available completed NCT01094964
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer treatment 3 unknown_status NCT03122964
Multi Institutional Study in Patient Presenting With Hematuria No drug interventions Not Available Not Available unknown_status NCT06447064
Cancer Loyalty Card Study 2 (CLOCS-2) No drug interventions Not Available Not Available recruiting NCT05878964
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. No drug interventions Not Available Not Available recruiting NCT01314664
A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC) No drug interventions Not Available Not Available terminated NCT02852564
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection treatment 1 completed NCT00623064
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer treatment 1 completed NCT06255964
A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer No drug interventions treatment 1 / 2 not_yet_recruiting NCT06541821
Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients No drug interventions Not Available Not Available enrolling_by_invitation NCT00556621
Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer treatment 1 / 2 completed NCT01915121
An Educational Intervention for Patients With Bladder Cancer No drug interventions treatment Not Available completed NCT01343121
Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy No drug interventions other Not Available completed NCT04723121
Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers No drug interventions diagnostic Not Available completed NCT01469221
Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) treatment 3 terminated NCT02500121
Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer treatment 2 completed NCT00648102
Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer No drug interventions treatment 1 completed NCT05714202
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) treatment 3 recruiting NCT01142102
Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer No drug interventions treatment Not Available completed NCT03864302
Simulation in Transurethral Bladder Cancer Surgery No drug interventions other Not Available unknown_status NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT03673202
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma No drug interventions Not Available Not Available unknown_status NCT03274284
Chemoradiotherapy for Recurrent T1G3 Bladder Cancer No drug interventions treatment 4 unknown_status NCT03790384
Sequential Combination Therapy in Bladder Cancer treatment 4 unknown_status NCT02989584
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer treatment 1 / 2 active_not_recruiting NCT00002684
Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer treatment 2 completed NCT00567684
Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors No drug interventions diagnostic Not Available active_not_recruiting NCT05715684
Patient-Centered Surgical Prehabilitation No drug interventions supportive_care Not Available recruiting NCT05154084
RESECT: Improving Quality in TURBT Surgery. No drug interventions Not Available Not Available completed NCT02560584
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting diagnostic 3 completed NCT00026884
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease No drug interventions Not Available Not Available recruiting NCT06337084
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors No drug interventions diagnostic 1 recruiting NCT06152679
Day-case Endourology; Patient Experience No drug interventions Not Available Not Available recruiting NCT00003779
Biological Therapy in Treating Patients With Bladder Cancer No drug interventions treatment 3 completed NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04289779
Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer treatment 2 recruiting NCT05037279
Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) treatment 3 not_yet_recruiting NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene No drug interventions treatment 1 / 2 completed NCT05018442
89Zr-girentuximab PET in Urothelial Cancer Patients diagnostic 1 / 2 recruiting NCT00589017
Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy treatment 2 recruiting